PROGRAM
Thursday 9th October 2025
| 0900 - 1215 | Workshop 1 - The Power of AI in Medicine & How to Get Started | Lindsay Page & Laura Hatton Daniel de Viana |
| 0900 - 1215 | Workshop 2 - Updates in Radiation Oncology Topics
| Orit Kaidar-Person |
| 0900 - 1215 | Workshop 3 - Mastering Perforator Flaps in Breast Surgery: Principles, Techniques and Refinements Topics
| Ashutosh Kothari, Peter Barry, Farid Meybodi, Peter Chin |
| 0900 - 1215 | Workshop 4 - Endocrine Deprivation in Breast Cancer Treatment: Managing the Fallout Details about this workshop can be found here | Virginia Baird |
| 1215 - 1315 | Lunch - for Workshop Attendees | |
| 1230 - 1315 | POSTER DISPLAY - AUTHORS PRESENT | |
| 1315 | Conference Opening and Welcome to country | |
| 1315 - 1530 | Session 1 - Hot Topics & Controversies in 2025 Neoadjuvant systemic therapy and radiotherapy implications 2025 - what is the evidence? Do anthracyclines still have a place in early breast cancer treatment? What the HER2? Pushing the boundaries of breast conserving surgery The patient voice: unmet needs and realities of breast cancer treatment | Orit Kaidar-Person Matteo Lambertini Elena Provenzano Ashutosh Kothari Emily Duncan, BCNA Seat at the Table (SATT) Consumer Representative |
| 1600 - 1745 | Session 2 - Wellbeing and Communication KEYNOTE: When words matter: communicating with the well-informed patient Hormone replacement in breast cancer patients: a controversy revisited Harnessing AI for Communication Excellence Lessons, losses and hope: a Medical Oncologist reflects Q&A panel | Lesley Fallowfield Rhea Liang Dawid Naude Nicholas Wilcken |
| 1745 - 1945 | Social Function - Welcome/Networking Event (Exhibition Area) |
Friday 10th October 2025
| 0715 - 830 | Industry Breakfast Session Title: Precision Medicine in Breast Cancer: Necessity of Hype? Speaker: Prof Matteo Lambertini | |
| 0715 - 830 | Industry Breakfast Session Title: Optimising outcome in oncoplastic and high risk patients Speaker: Dr Chilton Chong | |
| 0845 - 1035 | Session 3 - Risk Assessment and screening strategies KEYNOTE: Talking about risk & uncertainty in genetic testing Next-Gen screening: a look at risk-stratified trials & protocols Is hormone therapy safe for high-risk women without breast cancer? Revolutionising BreastScreen: a year of live AI readings in NSW The Lancet Breast Cancer Commission - a roadmap for personalising breast cancer prevention Q&A panel | Lesley Fallowfield Nehmat Houssami Rhea Liang Matthew Warner-Smith Kelly Anne Phillips |
| 1100 - 1245 | Session 4 - The Neoadjuvant multidisciplinary approach to management of breast cancer - the complexities Case Study 1 - Timing, sequencing and surgery: a complex case of high-risk breast cancer Case Study 2 - Young and ER-Positive: navigating the challenges of endocrine therapy intolerance The pathological assessment of neoadjuvant treated breast cancer Preoperative endocrine therapy as a functional biomarker in ER+ breast cancer Q&A panel | Tivya Kulasegaran Tivya Kulasegaran Elena Provenzano Belinda Yeo Matteo Lambertini, Ash Kothari. Elena Provenzano, Philip Poortmans, Orit Kaidar-Person, Lesley Fallowfield, Belinda Yeo, Owen Ung, Cameron Snell, Gillian Lamoury |
| 1245 - 1345 | Lunch in Trade Area POSTER DISPLAY - AUTHORS PRESENT | |
| 1245 | ASBD AGM | |
| 1345 - 1530 | Session 5 Rapid fire - Abstracts and oral presentations KEYNOTE: The young premenopausal woman the issues facing fertility, survivorship, pregnancy and genetic implications Q & A 4 x 7 minute oral presentations Q & A 4 x 7 minute oral presentations Q & A | Matteo Lambertini |
| 1600 - 1730 | Session 6 - Innovation and Advances KEYNOTE: AI, Digital Biomarkers - integration of AI into breast cancer pathology Smarter Surgery: Strategies to lower re-excision rates Innovations in Imaging: The PET trial and next-generation PET modalities The therapeutic value of mainstream genetic testing Q&A panel | Elena Provenzano Ashutosh Kothari Remy Lim Annabel Goodwin |
| 1900 - 2300 | Conference Dinner - QT Hotel Sponsored by |
Saturday 11th October 2025
| 0715 - 830 | Industry Breakfast Session Title: Putting Patients First: Multidisciplinary Strategies for Managing Adverse Events in Patients Treated with KEYTRUDA® (pembrolizumab) in High-Risk Early Stage TNBC | |
| 0715 - 830 | Industry Breakfast Session Title: Bridging the Gap: A Multidisciplinary Morning on Regional and Remote Challenges in Breast Care Description: Join Siemens Healthineers for an engaging breakfast panel discussion bringing together leading experts from across the breast care continuum - including breast imaging, surgery, and radiation oncology - to explore the current landscape of breast disease management in Australia and New Zealand. This multidisciplinary panel will explore the unique challenges faced by patients and clinicians in remote and regional communities, along with emerging trends and technologies in breast care that have the potential to bridge the access gap and promote greater equity for everyone, everywhere, sustainably. From disparities in access to leading technologies and workforce shortages, to diagnostic delays and infrastructure gaps, our panelists will share insights from the front lines and offer practical strategies to drive equitable outcomes across the healthcare system. This session promises thought-provoking discussion, cross-disciplinary perspectives, and a collaborative environment - over breakfast. Whether you're a clinician, policy maker, department administrator or healthcare innovator, this event offers a valuable opportunity to be part of the conversation shaping the future of breast care in our most underserved regions. | |
| 0845 - 1030 | Session 7 - Concurrent Sessions 7A Surgery and Radiotherapy - Updates in Management Global trends in training and practice of Oncoplastic Breast Surgery Sentinel Node Mapping: options beyond Tc99 TAD talk: a practical review of Axillary De-escalation Debate: Management of residual nodal disease after NACT Q&A panel 7B Medical Oncology - Estrogen receptor positive disease De-escalation in early HER2+ and TNBC: opportunities for tailored treatment HER2 is only half the story: the critical role of ER in HER2+ breast cancer What's next? Evolving treatment strategies after CDK4/6 inhibition progression All CLEAR - a strategy aiming at zero deaths from breast cancer Redefining phase 1: a first step, not a final hope Q&A panel | Ashutosh Kothari Peter Barry Farid Meybodi For further surgery: Ashutosh Kothari For radiotherapy: Orit Kaidar-Person Belinda Yeo Nicholas Wilcken Matteo Lambertini Christine Chaffer Dhanusha Sabanathan |
| 1100 - 1245 | Session 8 - Survivorship KEYNOTE: Key learnings from a real-world survivorship clinic Managing long term toxicities - bone matters Managing long term toxicities - heart matters Lymphoedema & Musculoskeletal issues update Nutrition, diets and supplements - navigating the plethora of information Q&A panel | Kim Kerin-Ayres Mike Lin Matthew Burrage Robyn Box Rewa Keegan |
| 1245 - 1330 | Lunch in Trade Area POSTER DISPLAY - AUTHORS PRESENT | |
| 1330 - 1500 | Session 9 - The last word on controversies panel Are we overtreating the low-risk cancer? High breast density: what now? Fibroepithelial lesions and predicting behaviour Radiotherapy to implant reconstruction and after skin sparing mastectomy Last chance questions - ask before it's too late! | Philip Poortmans Nehmat Houssami Sandra O'Toole Orit Kaidar-Person |
| 1515 | Conference Close | Peter Chin & Maree Colosimo |
*Times are subject to change
CONTACT US
Impact Events ABN 45 094 598 339
Address: Unit 24, Level 3, 2 Brandon Park Drive, Wheelers
Hill Victoria 3150 Australia
Phone: 1300 061 814 or +61 3 8657 4987 Email: info@impactevents.com.au